123 Results

People

  1. Gonen
    Gonen
  2. Schoder
    Schoder
  3. Larson
    Larson
  4. Moskowitz
    Moskowitz
  5. Vargas Alvarez
    Vargas Alvarez
  6. Hricak
    Hricak
  7. Zheng
    Zheng
  8. Scher
    Scher
  9. Sala
    Sala
  10. Akin
    Akin

Groups

  1. Epidemiology and Biostatistics (123)
  2. Molecular Imaging and Therapy Service (123)
  3. Radiology, Department of (117)
  4. Biostatistics Service (116)
  5. GSK Faculty (82)
  6. Molecular Pharmacology and Chemistry Program Faculty (72)
  7. Sloan Kettering Institute Faculty (72)
  8. Center for Pancreatic Cancer Research (59)
  9. Department of Medicine (59)
  10. Surgery (54)
  1. "aged"
  2. "Journal article"
  3. "Epidemiology and Biostatistics"
  4. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (123)
Groups
  1. Epidemiology and Biostatistics (123)
  2. Molecular Imaging and Therapy Service (123)
  3. Radiology, Department of (117)
  4. Biostatistics Service (116)
  5. GSK Faculty (82)
  6. Molecular Pharmacology and Chemistry Program Faculty (72)

More Groups

People
  1. Steven Larson (50)
  2. Mithat Gonen (45)
  3. Heiko Schoder (34)
  4. Chaya Moskowitz (25)
  5. Hebert Vargas Alvarez (25)
  6. Hedvig Hricak (23)

More People

Years
  1. 2024 (2)
  2. 2023 (4)
  3. 2022 (5)
  4. 2021 (2)
  5. 2020 (8)
  6. 2019 (4)

More Years

Publications
  1. Radiology (17)
  2. Journal of Nuclear Medicine (16)
  3. Journal of Clinical Oncology (12)
  4. Clinical Cancer Research (9)
  5. American Journal of Roentgenology (8)
  6. European Journal of Nuclear Medicine and Molecular Imaging (5)

More Publications

Publishers
  1. Radiological Society of North America, Inc. (17)
  2. Society of Nuclear Medicine (16)
  3. American Society of Clinical Oncology (14)
  4. Springer (14)
  5. American Association for Cancer Research (10)
  6. American Roentgen Ray Society (8)

More Publishers

Results (123)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-in-human evaluation of site-specifically labeled (89)Zr-pertuzumab in patients with HER2-positive breast cancer
    Journal Article

    Yeh, R.; O'Donoghue, J. A.; Jayaprakasam, V. S.; Mauguen, A.; Min, R.; Park, S.; Brockway, J. P.; Bromberg, J. F.; Zhi, W. I.; Robson, M. E.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Synoptic reporting for pretreatment CT examination in patients with advanced ovarian cancer: Impact on documentation of disease sites and physician satisfaction
    Journal Article

    Andrieu, P. C.; Nikolovski, I.; Juluru, K.; Sadowski, E.; Gangai, N.; Zheng, J.; Capanu, M.; Praiss, A. M.; Nougaret, S.; Shinagare, A. B.; more...
    American Journal of Roentgenology (2023)

    Fulltext@MSK | Save
  • Long-term prognostic value of (82)Rb PET/CT-determined myocardial perfusion and flow reserve in cancer patients
    Journal Article

    Fox, J. J.; Mauguen, A.; Ito, K.; Gupta, D.; Yu, A.; Schindler, T. H.; Strauss, H. W.; Schöder, H.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Interim analysis of a prospective validation of 2 blood-based genomic assessments (PPQ and NETest) to determine the clinical efficacy of (177)Lu-DOTATATE in neuroendocrine tumors
    Journal Article

    Bodei, L.; Raj, N.; Do, R. K.; Mauguen, A.; Krebs, S.; Reidy-Lagunes, D.; Schöder, H.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Failure patterns by PSMA PET for recurrent prostate cancer after prostatectomy and salvage radiation
    Journal Article

    Imber, B. S.; O'Dwyer, E.; Lobaugh, S.; McBride, S. M.; Hopkins, M.; Kollmeier, M.; Gorovets, D.; Brennan, V.; Pike, L. R. G.; Gewanter, R.; more...
    Urology (2022)

    Fulltext@MSK | Save
  • 1(8)F-FDG PET/CT for post-treatment surveillance imaging of patients with stage III Merkel cell carcinoma
    Journal Article

    Mahajan, S.; Barker, C. A.; Mauguen, A.; D’Angelo, S. P.; Yeh, R.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2022)

    Fulltext@MSK | Save
  • MRI screening of BRCA mutation carriers: Comparison of standard protocol and abbreviated protocols with and without T2-weighted images
    Journal Article

    Naranjo, I. D.; Sogani, J.; Saccarelli, C.; Horvat, J. V.; Sevilimedu, V.; Hughes, M. C.; Lo Gullo, R.; Jochelson, M. S.; Reiner, J.; Pinker, K.
    American Journal of Roentgenology (2022)

    Fulltext@MSK | Save
  • Mobile mammography in New York City: Analysis of 32,350 women utilizing a screening mammogram program
    Journal Article

    Botty van den Bruele, A.; Sevilimedu, V.; Jochelson, M.; Formenti, S.; Norton, L.; Sacchini, V.
    npj Breast Cancer (2022)

    Fulltext@MSK | Save